Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.25.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.25.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.25.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.25.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.13.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.13.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.13.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.13.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.13.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DU.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DU.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DU.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DU.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.53EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used